NIH-funded research R01 grant

Understanding and treating eye problems in premature infants caused by oxygen exposure

Official title: Metabolic basis of retinopathy of prematurity and potential treatment with anaplerotic substrates

Funded at Tufts Medical Center · NIH-11050747 · Data updated 2026-11-12

This study is looking at how too much oxygen can affect the eyes of premature babies and hopes to find out if certain nutrients in breast milk can help improve their eye health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTufts Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startApril 1, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$462,072
NIH project number1R01EY035701-01A1
Project IDNIH-11050747 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are premature infants, particularly those born with low birth weight who are at higher risk for developing ROP.

Less likely to help

Patients who are not premature or do not exhibit symptoms of retinopathy of prematurity may not benefit from this research.

What this research studies

This research investigates how exposure to high levels of oxygen affects the development of the retina in premature infants, leading to a condition known as retinopathy of prematurity (ROP). The study focuses on the metabolic processes in the liver that contribute to ROP and explores the potential of using specific nutrients to improve retinal health. By examining the role of different fatty acids in breast milk and their impact on infant metabolism, the research aims to identify new treatment strategies that could enhance retinal development in these vulnerable infants.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for preventing vision loss in premature infants affected by retinopathy of prematurity.

How similar studies have gone: Previous research has shown promising results in understanding the metabolic factors contributing to ROP, indicating that this approach may lead to significant advancements in treatment.

Where this research is happening

  • Tufts Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Singh, Charandeep — Tufts Medical Center
  • Study coordinator: Singh, Charandeep

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.